Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor
about
PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein BPILR and PILR have a siglec fold and provide the basis of binding to sialic acidStructural basis for simultaneous recognition of an O-glycan and its attached peptide of mucin family by immune receptor PILRThe SIRP family of receptors and immune regulationAn essential role of sialylated O-linked sugar chains in the recognition of mouse CD99 by paired Ig-like type 2 receptor (PILR)TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injuryThe myeloid receptor PILRβ mediates the balance of inflammatory responses through regulation of IL-27 productionAlzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.Functional analysis of activating receptor LMIR4 as a counterpart of inhibitory receptor LMIR3.A simple detection method for low-affinity membrane protein interactions by baculoviral display.Modulation of paired immunoglobulin-like type 2 receptor signaling alters the host response to Staphylococcus aureus-induced pneumoniaInteraction between the mouse homologue of CD99 and its ligand PILR as a mechanism of T cell receptor-independent thymocyte apoptosis.PANP is a novel O-glycosylated PILRα ligand expressed in neural tissues.A single-amino-acid substitution in herpes simplex virus 1 envelope glycoprotein B at a site required for binding to the paired immunoglobulin-like type 2 receptor alpha (PILRalpha) abrogates PILRalpha-dependent viral entry and reduces pathogenesisEvolutionarily conserved paired immunoglobulin-like receptor α (PILRα) domain mediates its interaction with diverse sialylated ligands.Comparative analysis of the paired immunoglobulin-like receptor (PILR) locus in six mammalian genomes: duplication, conversion, and the birth of new genes.DAP12: an adapter protein with dual functionality.CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2.Expression, crystallization and preliminary X-ray diffraction analysis of human paired Ig-like type 2 receptor alpha (PILRalpha).Entry of herpes simplex virus 1 and other alphaherpesviruses via the paired immunoglobulin-like type 2 receptor alpha.Differential effects on cell fusion activity of mutations in herpes simplex virus 1 glycoprotein B (gB) dependent on whether a gD receptor or a gB receptor is overexpressedEffector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoireEpsinR, a target for pyrenocine B, role in endogenous MHC-II-restricted antigen presentation.Maternal age effects on myometrial expression of contractile proteins, uterine gene expression, and contractile activity during labor in the ratHerpes B virus utilizes human nectin-1 but not HVEM or PILRα for cell-cell fusion and virus entry.Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia.Role of ITAM-containing adapter proteins and their receptors in the immune system and bone.Drosophila Schneider 2 (S2) cells: a novel tool for studying HSV-induced membrane fusionTransport of misfolded endoplasmic reticulum proteins to the cell surface by MHC class II molecules.CD134 is a cellular receptor specific for human herpesvirus-6B entry.Targeting CD22 reprograms B-cells and reverses autoimmune diabetes.Paired Ig-Like Type 2 Receptor-Derived Agonist Ligands Ameliorate Inflammatory Reactions by Downregulating β1 Integrin Activity.Cross-regulation between herpesviruses and the TNF superfamily membersInteraction of CD99 with its paralog CD99L2 positively regulates CD99L2 trafficking to cell surfacesDAP10- and DAP12-associated receptors in innate immunity.CD99-dependent expansion of myeloid-derived suppressor cells and attenuation of graft-versus-host disease.PILRα binds an unknown receptor expressed primarily on CD56bright and decidual-NK cells and activates NK cell functionsImmune inhibitory receptors: essential regulators of phagocyte function.Nonmuscle myosin heavy chain IIb mediates herpes simplex virus 1 entryBordetella dermonecrotic toxin binds to target cells via the N-terminal 30 amino acids.
P2860
Q24313362-F35898B6-E4BF-4555-AF27-68F98CBCEB70Q27683849-7F5BC5EE-1FFE-4208-BF41-12EC3B6D6A73Q27684050-511A2330-74CD-4DBB-B7B7-3DE3AC39332CQ28239784-73F68C1F-F347-472F-9F1F-18427472172AQ28589761-93E5CFBA-70D2-422D-A5A5-B014F02E1D3FQ28591447-4C43AA1B-A50F-4DF3-B6FD-7F01F83AA457Q28730911-82CD9865-685E-4381-AA8A-C347161B3684Q30360286-7FFC8B60-B182-44A5-BAFC-15D48CFFD28EQ31109562-EF033219-4105-446D-8E17-6B414EE4C184Q33395661-65C4C40C-B1AA-4A09-9649-A4B08B08C707Q33675732-4F755E87-5942-409A-BCD2-509811033BA1Q33879825-F43F73C3-96B7-4910-82B2-E92DABB7A085Q34159442-F972E632-E7FC-435D-AC96-4A21731D4967Q34178357-37BD2D68-7758-4C2C-A0B1-F1EE622970ADQ34259322-40795F78-C4CE-43BE-A11C-0B9C4D165A27Q34559680-BEEB9B3E-8DB5-424B-A06D-190DAA8A28A4Q34581211-37645C66-A3FA-455F-A827-8A447DADE391Q34629236-104A50D9-24B9-4C1A-928E-FC42D0B1D13FQ34728378-1FC10A53-0098-4ED6-BD6F-1E4D2F7A8C97Q34952284-C22D0AA0-4F96-4A4E-A30A-0009D6A14FA8Q34982160-05C24C36-9EC6-48C4-917A-573A2324FF74Q35090079-DF9C9157-7E5E-43D1-AE69-CE525268A8A1Q35241354-8CEE70F3-368E-4685-A375-89064BBE5BF1Q35588574-0C9AA87B-AF55-499D-9207-24912F09AA56Q35868024-BA797C99-51F3-4AB3-BCC8-1577ED3D371AQ36148572-C69F3FC1-4B1E-4873-8874-C5677C0A29D6Q36324920-73876375-A6A1-4FBE-AD30-33E58B25079DQ36625628-92A556DD-906D-4004-8A48-53A42B0997F3Q36685319-9185D6DC-2D07-457C-B4F8-708E2FDC6CA1Q36895490-0D4D8D13-1360-471B-86D6-D4582C7EA627Q36943737-233829BC-4C5A-4B42-BED9-C9EE94547B4DQ37121871-DD8409FF-F6FC-4030-BE34-3C1114E30302Q37307520-687D134E-BC4A-427B-8FD7-54B2A48FEC3EQ37317147-A6E0642A-97CE-4E4F-8B67-412F2E71BD43Q37361459-CD4BD83F-A92C-4B16-8364-354D6D367DBEQ37461490-43373BF9-EE73-4DDC-9EC7-44AEC8DA213DQ37520120-1DB4AFB9-0743-4F84-9C1F-70816474DE70Q37839870-34E3B68C-3C42-476D-B8D5-8714EF526DC3Q38937427-85D3942F-5806-403D-A55D-72CA1B5CC7F2Q39612530-36E8A238-BBD0-47CE-8D1E-4556A1BB2434
P2860
Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor
description
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
im Februar 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/02/16)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/02/16)
@nl
наукова стаття, опублікована в лютому 2004
@uk
مقالة علمية (نشرت في 16-2-2004)
@ar
name
Activation of natural killer c ...... oglobulin-like type 2 receptor
@ast
Activation of natural killer c ...... oglobulin-like type 2 receptor
@en
Activation of natural killer c ...... oglobulin-like type 2 receptor
@nl
type
label
Activation of natural killer c ...... oglobulin-like type 2 receptor
@ast
Activation of natural killer c ...... oglobulin-like type 2 receptor
@en
Activation of natural killer c ...... oglobulin-like type 2 receptor
@nl
prefLabel
Activation of natural killer c ...... oglobulin-like type 2 receptor
@ast
Activation of natural killer c ...... oglobulin-like type 2 receptor
@en
Activation of natural killer c ...... oglobulin-like type 2 receptor
@nl
P2860
P50
P3181
P356
P1476
Activation of natural killer c ...... oglobulin-like type 2 receptor
@en
P2093
Kouetsu Ogasawara
Lewis L. Lanier
P2860
P304
P3181
P356
10.1084/JEM.20031885
P407
P577
2004-02-16T00:00:00Z